Evidence map›Paper›PMID 42667167›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Optimized Cas9-Enriched Nanopore Sequencing and Analysis Workflow for Clinical Diagnosis of Repeat Expansion Disorders.

Seungbok Lee, Chanju Jung, Minjeong Kim, Narae Kim, Gue-Ho Hwang, Soon-Tae Lee, Kon Chu, Sang Kun Lee, Han-Joon Kim, Jong-Hee Chae and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Seungbok Lee *Department of Genomic Medicine, Seoul National University Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0002-3145-8714
Chanju Jung *Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.ORCID https://orcid.org/0009-0007-7714-866X
Minjeong Kim *Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.ORCID https://orcid.org/0009-0005-2003-7374
Narae KimDepartment of Neurology, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0001-9173-922X
Gue-Ho HwangDepartment of Chemistry, Hanyang University, Seoul, South Korea.ORCID https://orcid.org/0000-0002-4201-0974
Soon-Tae LeeDepartment of Neurology, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0003-4767-7564
Kon ChuDepartment of Neurology, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0001-5863-0302
Sang Kun LeeDepartment of Neurology, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.
Han-Joon KimDepartment of Neurology, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0001-8219-9663
Jong-Hee ChaeDepartment of Genomic Medicine, Seoul National University Hospital, Seoul, South Korea.
Sangsu BaeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.ORCID https://orcid.org/0000-0003-3615-8566
Jangsup MoonDepartment of Genomic Medicine, Seoul National University Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0003-1282-4528

Funding

Korea Health Industry Development Institute RS-2026-25618734Ministry of Food and Drug Safety 25202MFDS003National Research Foundation of Korea RS-2024-00344068SNUH Lee Kun-hee Child Cancer & Rare Disease Project 25B-001-0700
6 · The paper itself

Abstract

Short tandem repeat (STR) expansion is a major genetic mechanism underlying numerous neurogenetic disorders. However, traditional PCR amplification and short-read next-generation sequencing-based methods often fail to detect large-scale, complex expansions and to capture methylation information. Thus, this study aimed to modify an amplification-free nanopore Cas9-targeted sequencing (nCATS) platform to achieve uniform coverage across 56 currently defined STR loci using a single test with genomic DNA from patient-derived blood cells and to develop a dedicated analysis algorithm, STRiker, capable of identifying internal motif contexts and de novo repeat structures. Ultimately, this study identified pathogenic repeat expansions in 12 of 37 patients (32.4%) with cerebellar ataxia who remained genetically undiagnosed despite extensive prior genetic testing, in FGF14 (n = 4), ATXN8OS, NOP56, RFC1 (n = 2 each), and PRNP and NOTCH2NLC (n = 1 each). Additionally, family-based cascade screening revealed six relatives with repeat expansions in five families. These results demonstrate a broader diversity of pathogenic repeat structures, particularly in FGF14, and illustrate that CpG methylation can mitigate the pathogenic effects of repeat expansions. This nCATS-STRiker workflow offers a powerful strategy for improving the diagnosis of STR-related neurogenetic diseases, such as cerebellar ataxia and other diseases.

Indexed as

Cas9 enrichmentmethylation analysisnanopore sequencingrepeat expansionshort tandem repeatsspinocerebellar ataxia

Identifiers

PMID42667167
PMCPMC13525614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.